Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-59 of 59 for breast cancer, female

Edit search filters
  1. Genetics of Chemotherapy-Related Amenorrhea in Breast Cancer Survivors

    Rochester, MN

  2. Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia

    Rochester, MN, Albert Lea, MN, Mankato, MN

  3. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

    Rochester, MN

  5. A Study to Analyze Symptoms and Quality of Life Issues in Women Living with Metastatic Breast Cancer

    Jacksonville, FL

  6. A Study to Evaluate Left and Right Ventricular Function in Relation to Exercise Capacity in Breast Cancer Survivors

    Jacksonville, FL

  7. A Study to Evaluate Circulating Tumor DNA (ctDNA) and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer

    Rochester, MN

  8. A Study to Collect and Correlate the Data from Multiple Risk Assessments for Heart Toxicity in Patients Receiving Chemotherapy for Breast Cancer

    Rochester, MN

  9. A Study to Evaluate Hormone Concentrations in Patients with Metastatic Cancer

    Rochester, MN

.

Mayo Clinic Footer